Cargando…

Recurrent Vitreomacular Traction in a Patient Treated with Ocriplasmin: A Case Report

INTRODUCTION: To describe a case of recurrent vitreomacular traction and macular edema that appeared both before and after the intravitreal injection of ocriplasmin. CASE REPORT: An 82-year-old monocular man presented with metamorphopsia and reduced vision of 1-week duration. The patient’s general m...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsanos, Andreas, Gorgoli, Konstantina, Asproudis, Ioannis, Stefaniotou, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886937/
https://www.ncbi.nlm.nih.gov/pubmed/33108639
http://dx.doi.org/10.1007/s40123-020-00316-z
_version_ 1783651903958155264
author Katsanos, Andreas
Gorgoli, Konstantina
Asproudis, Ioannis
Stefaniotou, Maria
author_facet Katsanos, Andreas
Gorgoli, Konstantina
Asproudis, Ioannis
Stefaniotou, Maria
author_sort Katsanos, Andreas
collection PubMed
description INTRODUCTION: To describe a case of recurrent vitreomacular traction and macular edema that appeared both before and after the intravitreal injection of ocriplasmin. CASE REPORT: An 82-year-old monocular man presented with metamorphopsia and reduced vision of 1-week duration. The patient’s general medical history was unremarkable. His ophthalmic history was significant for severe ocular trauma in the right eye in childhood that caused phthisis. The left eye had undergone uncomplicated phacoemulsification 3 months earlier and the 1-month postoperative best corrected visual acuity (BCVA) was logarithmic mean angle of resolution (logMAR) 0.0. There was no history of other ocular conditions. At presentation, BCVA was logMAR 0.2 and optical coherence tomography (OCT) revealed the presence of cystoid macular edema caused by vitreomacular traction (VMT). The patient was scheduled for intravitreal ocriplasmin injection. Prior to treatment, the vision improved spontaneously to logMAR 0.1, and no VMT could be detected with spectral domain (SD)-OCT. The ocriplasmin injection was deferred but 3 weeks later the patient presented again with metamorphopsia, while VMT was again evident on SD-OCT. Ocriplasmin was injected and 1 month later the BCVA reached logMAR 0.1 without VMT. However, at 2 months post injection the VMT reappeared and a conservative approach with observation and topical nepafenac administration was decided. At the 3-month post-injection visit there was no VMT. More than 3 years after the ocriplasmin injection there is still no evidence of VMT, the patient is free of metamorphopsia, and his BCVA is logMAR 0.0. CONCLUSION: Separation of consecutive layers of the vitreous cortex (vitreoschisis) may account for recurrent VMT.
format Online
Article
Text
id pubmed-7886937
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-78869372021-03-03 Recurrent Vitreomacular Traction in a Patient Treated with Ocriplasmin: A Case Report Katsanos, Andreas Gorgoli, Konstantina Asproudis, Ioannis Stefaniotou, Maria Ophthalmol Ther Case Report INTRODUCTION: To describe a case of recurrent vitreomacular traction and macular edema that appeared both before and after the intravitreal injection of ocriplasmin. CASE REPORT: An 82-year-old monocular man presented with metamorphopsia and reduced vision of 1-week duration. The patient’s general medical history was unremarkable. His ophthalmic history was significant for severe ocular trauma in the right eye in childhood that caused phthisis. The left eye had undergone uncomplicated phacoemulsification 3 months earlier and the 1-month postoperative best corrected visual acuity (BCVA) was logarithmic mean angle of resolution (logMAR) 0.0. There was no history of other ocular conditions. At presentation, BCVA was logMAR 0.2 and optical coherence tomography (OCT) revealed the presence of cystoid macular edema caused by vitreomacular traction (VMT). The patient was scheduled for intravitreal ocriplasmin injection. Prior to treatment, the vision improved spontaneously to logMAR 0.1, and no VMT could be detected with spectral domain (SD)-OCT. The ocriplasmin injection was deferred but 3 weeks later the patient presented again with metamorphopsia, while VMT was again evident on SD-OCT. Ocriplasmin was injected and 1 month later the BCVA reached logMAR 0.1 without VMT. However, at 2 months post injection the VMT reappeared and a conservative approach with observation and topical nepafenac administration was decided. At the 3-month post-injection visit there was no VMT. More than 3 years after the ocriplasmin injection there is still no evidence of VMT, the patient is free of metamorphopsia, and his BCVA is logMAR 0.0. CONCLUSION: Separation of consecutive layers of the vitreous cortex (vitreoschisis) may account for recurrent VMT. Springer Healthcare 2020-10-27 2021-03 /pmc/articles/PMC7886937/ /pubmed/33108639 http://dx.doi.org/10.1007/s40123-020-00316-z Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Case Report
Katsanos, Andreas
Gorgoli, Konstantina
Asproudis, Ioannis
Stefaniotou, Maria
Recurrent Vitreomacular Traction in a Patient Treated with Ocriplasmin: A Case Report
title Recurrent Vitreomacular Traction in a Patient Treated with Ocriplasmin: A Case Report
title_full Recurrent Vitreomacular Traction in a Patient Treated with Ocriplasmin: A Case Report
title_fullStr Recurrent Vitreomacular Traction in a Patient Treated with Ocriplasmin: A Case Report
title_full_unstemmed Recurrent Vitreomacular Traction in a Patient Treated with Ocriplasmin: A Case Report
title_short Recurrent Vitreomacular Traction in a Patient Treated with Ocriplasmin: A Case Report
title_sort recurrent vitreomacular traction in a patient treated with ocriplasmin: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886937/
https://www.ncbi.nlm.nih.gov/pubmed/33108639
http://dx.doi.org/10.1007/s40123-020-00316-z
work_keys_str_mv AT katsanosandreas recurrentvitreomaculartractioninapatienttreatedwithocriplasminacasereport
AT gorgolikonstantina recurrentvitreomaculartractioninapatienttreatedwithocriplasminacasereport
AT asproudisioannis recurrentvitreomaculartractioninapatienttreatedwithocriplasminacasereport
AT stefaniotoumaria recurrentvitreomaculartractioninapatienttreatedwithocriplasminacasereport